Cardiovascular Complications in Vascular Connective Tissue Disorders After COVID-19 Infection and Vaccination

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Dec 20

PMID 39705273

Authors

Anthony L Guerrerio

Allyson Mateja

Gretchen MacCarrick

Jonathan Fintzi

Erica Brittain

Pamela A Frischmeyer-Guerrerio

Harry C Dietz

Affiliations

Soon will be listed here.

Abstract

Background: COVID-19 infection and vaccination have been reported to confer an elevated risk for cardiovascular events (CVE). We sought to determine whether individuals with an underlying vascular connective tissue disorder including Marfan syndrome (MFS), Loeys-Dietz syndrome (LDS), or vascular Ehlers Danlos syndrome (vEDS) are at increased risk for cardiac events after COVID-19 infection or vaccination.

Methods: 325 respondents self-reported data through a cross-sectional, web-based survey available from 22 November 2021, through 15 March 2022 regarding COVID-19 illness and vaccinations, the occurrence of any CVE, and adverse events following vaccination. The data were analyzed using a Cox proportional hazards model with time varying indicators for COVID-19 illness/vaccination in the preceding 30 days.

Results: COVID-19 illness was significantly associated with an increased rate of a new abnormal heart rhythm 30 days following infection. No other CVEs were reported in the 90 days after COVID-19 illness. We did not find evidence of an increased rate of any CVE in the 30 days following any COVID-19 vaccination dose.

Conclusion: In respondents with MFS, LDS, or vEDS, we uncovered no evidence of an increase in CVEs in the 30 days following COVID-19 illness, with the possible exception of dysrhythmia. In light of the absence of a substantial increase in self-reported CVEs in the 30 days following COVID-19 vaccination, these data are in keeping with the recommendation from the Marfan Foundation Professional Advisory Board that all eligible persons be vaccinated for COVID-19.

References

Haas J, Bender F, Ballou S, Kelley J, Wilhelm M, Miller F . Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022; 5(1):e2143955. PMC: 8767431. DOI: 10.1001/jamanetworkopen.2021.43955. View

Bonetti P, Lerman L, Lerman A . Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003; 23(2):168-75. DOI: 10.1161/01.atv.0000051384.43104.fc. View

Gold M, MacDonald N, McMurtry C, Balakrishnan M, Heininger U, Menning L . Immunization stress-related response - Redefining immunization anxiety-related reaction as an adverse event following immunization. Vaccine. 2020; 38(14):3015-3020. DOI: 10.1016/j.vaccine.2020.02.046. View

Jaggers J, Wolfson A . mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation. Curr Allergy Asthma Rep. 2023; 23(3):195-200. PMC: 9869308. DOI: 10.1007/s11882-023-01065-2. View

Chen L, Hao G . The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease. Cardiovasc Res. 2020; 116(12):1932-1936. PMC: 7184394. DOI: 10.1093/cvr/cvaa093. View

Macy E, Pandya S, Sheikh J, Burnette A, Shi J, Chung J . Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions. J Allergy Clin Immunol Pract. 2021; 10(3):827-836. PMC: 8714255. DOI: 10.1016/j.jaip.2021.12.021. View

Maltezou H, Anastassopoulou C, Hatziantoniou S, Poland G, Tsakris A . Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines. Vaccine. 2021; 40(2):183-186. PMC: 8626274. DOI: 10.1016/j.vaccine.2021.11.066. View

Nzaji M, Kamenga J, Luhata Lungayo C, Bene A, Fezeu Meyou S, Kapit A . Factors associated with COVID-19 vaccine uptake and hesitancy among healthcare workers in the Democratic Republic of the Congo. PLOS Glob Public Health. 2024; 4(2):e0002772. PMC: 10833569. DOI: 10.1371/journal.pgph.0002772. View

Bowe B, Xie Y, Al-Aly Z . Postacute sequelae of COVID-19 at 2 years. Nat Med. 2023; 29(9):2347-2357. PMC: 10504070. DOI: 10.1038/s41591-023-02521-2. View

10.

Harris P, Taylor R, Minor B, Elliott V, Fernandez M, ONeal L . The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95:103208. PMC: 7254481. DOI: 10.1016/j.jbi.2019.103208. View

11.

Xie Y, Xu E, Bowe B, Al-Aly Z . Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022; 28(3):583-590. PMC: 8938267. DOI: 10.1038/s41591-022-01689-3. View

12.

Hara H, Takeda N, Fujiwara T, Yagi H, Maemura S, Kanaya T . Activation of TGF-β signaling in an aortic aneurysm in a patient with Loeys-Dietz syndrome caused by a novel loss-of-function variant of . Hum Genome Var. 2019; 6:6. PMC: 6338757. DOI: 10.1038/s41439-019-0038-x. View

13.

Malecki C, Hambly B, Jeremy R, Robertson E . The Role of Inflammation and Myeloperoxidase-Related Oxidative Stress in the Pathogenesis of Genetically Triggered Thoracic Aortic Aneurysms. Int J Mol Sci. 2020; 21(20). PMC: 7590002. DOI: 10.3390/ijms21207678. View

14.

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

15.

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

16.

Xu B, Iida Y, Glover K, Ge Y, Wang Y, Xuan H . Inhibition of VEGF (Vascular Endothelial Growth Factor)-A or its Receptor Activity Suppresses Experimental Aneurysm Progression in the Aortic Elastase Infusion Model. Arterioscler Thromb Vasc Biol. 2019; 39(8):1652-1666. PMC: 6699755. DOI: 10.1161/ATVBAHA.119.312497. View

17.

Ramandi A, Akbarzadeh M, Khaheshi I, Khalilian M . Aortic dissection and Covid-19; a comprehensive systematic review. Curr Probl Cardiol. 2022; 48(6):101129. PMC: 8817949. DOI: 10.1016/j.cpcardiol.2022.101129. View

18.

Patone M, Mei X, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M . Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2021; 28(2):410-422. PMC: 8863574. DOI: 10.1038/s41591-021-01630-0. View

19.

Lazea C, Bucerzan S, Crisan M, Al-Khzouz C, Miclea D, Sufana C . Cardiovascular manifestations in Marfan syndrome. Med Pharm Rep. 2021; 94(Suppl No 1):S25-S27. PMC: 8411824. DOI: 10.15386/mpr-2223. View

20.

Gallo E, Loch D, Habashi J, Calderon J, Chen Y, Bedja D . Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest. 2013; 124(1):448-60. PMC: 3871227. DOI: 10.1172/JCI69666. View